BIOGEN INC. (BIIB)

SEC fundamentals · as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Oct 30, 2026

Verified against EDGAR
Total Assets
$32.05B
Stockholders' Equity
$18.92B
Cash & Equivalents
$1.30B
Long-Term Debt
$7.29B

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Sep 30, 2026, BIOGEN INC. reported revenue of $2.80B, net income of -$20.6M, and total assets of $32.05B. Every figure below is taken directly from BIOGEN INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$14.38B$7.77B$1.16B
FY2016FY2019FY2022FY2025
Revenue$9.89BNet income$1.29B
FY2016 revenue
$11.45B
FY2025 revenue
$9.89B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$9.89B$1.29B
FY2024$9.68B$1.63B
FY2023$9.84B$1.16B
FY2022$10.17B$3.05B
FY2021$10.98B$1.56B
FY2020$13.44B$4.00B
FY2019$14.38B$5.89B
FY2018$13.45B$4.43B
FY2017$12.27B$2.54B
FY2016$11.45B$3.70B

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 28, 2026on EDGAR ↗
10-QOct 28, 2026on EDGAR ↗
8-KJul 29, 2026on EDGAR ↗
10-QJul 29, 2026on EDGAR ↗
8-KJul 1, 2026on EDGAR ↗
8-KJun 10, 2026on EDGAR ↗
8-KMay 14, 2026on EDGAR ↗
10-QApr 29, 2026on EDGAR ↗
8-KApr 29, 2026on EDGAR ↗
DEF 14AApr 28, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$32.05Bsource ↗
Stockholders’ Equity$18.92Bsource ↗
Cash & Equivalents$1.30Bsource ↗
Long-Term Debt$7.29Bsource ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue$2.80Bsource ↗
Net Income-$20.6Msource ↗
Pretax Income-$9.0Msource ↗
Gross Profit$2.06Bsource ↗
Cost of Revenue$748.4Msource ↗
R&D Expense$574.0Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-0.14source ↗
EPS (basic)$-0.14source ↗
Shares Outstanding147.8Msource ↗
Cash from Operations$640.8Msource ↗
Cash from Financing-$393.8Msource ↗
Cash from Investing-$222.1Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
2
Net shares
-1.2K

Restatement history

Point-in-time

10 of 614 annual fact-keys were materially restated between filings: what BIOGEN INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches BIIB’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BIIB

MCP tool: get_sec_fundamentals ticker=BIIB

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BIIB/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=BIIB as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BIIB/history

MCP tool: get_fundamentals_history ticker=BIIB

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/BIIB

MCP tool: get_financial_health ticker=BIIB

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.